Copyright MEDICINOVA, Inc. All Right Reserverd.
medicinova.jp was registered 1 decade 8 years ago. It has a alexa rank of #1,734,148 in the world. It is a domain having .jp extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, medicinova.jp is SAFE to browse.
Daily Unique Visitors: | 506 |
Daily Pageviews: | 1,012 |
Income Per Day: | $ 3.00 |
Estimated Worth: | $ 720.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 1,734,148 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
4 days ago ... MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of serious diseases ...
Find the latest MediciNova, Inc. (MNOV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get MediciNova Inc (4875.T-JP:Tokyo Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.
MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs ...
MediciNova Inc. Watchlist. 4875JP. Closed. Back To Top. Last Updated ...
Over 20 years ago, ibudilast was approved in Japan to treat post-stroke complications and asthma. Leadership at MediciNova plan to move the phase III trial ...
Dec 28, 2020 ... Japan Exchange Group (JPX) offers a one-stop shop for a range of products ... Reason, MediciNova, Inc. (hereinafter "the Company") has been ...
jobs with MediciNova, Inc. to view and apply for now with BioSpace. ... and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan.
Oral ibudilast has been launched in Japan as Ketas® by Kyorin Pharmaceutical as an anti-asthmatic agent. Allergic conjunctivitis. Ibudilast has been launched in ...
メディシノバは、十分な治療がまだ確立していない疾病を伴う患者さんに、よりよい ... 年9月30日号) (link: https://qr.paps.jp/Zo972 ) #メディシノバ #Medicinova.
メディシノバは、新規性のある治療薬のグローバル開発・販売に特化した製薬企業です。
Apr 18, 2017 ... 18 April 2017. Asia Pacific/Japan. Equity Research. Biotechnology (Biotechnology (Japan)). Medicinova (4875). INITIATION. Rating. OUTPERFORM.
Aug 15, 2019 ... MediciNova. Information provided by (Responsible Party):. MediciNova. Study Details; Tabular View · No Results Posted · Disclaimer ...
MN-001 produced anti-inflammatory effects in a variety of rodent models of IC and asthma; in these models, MN-001 reduced bladder hyper-reactivity much in the ...
MediciNova, Inc.×モーニングスター 特別対談~メディシノバの現状と今後の事業展望~MediciNova, Inc.(メディシノバ)代表取締役社長兼CEO 岩城 裕一 ...
MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small-molecule therapeutics for the treatment of serious diseases ...
MEDICINOVA AND AVIGEN STOCKHOLDERS APPROVE MERGER. SAN DIEGO, Calif., and ALAMEDA, Calif., December 17, 2009 — MediciNova, Inc., a biopharmaceutical company ...
Aug 12, 2021 ... MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for ...
Sep 2, 2021 ... LA JOLLA, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ...
Get the latest MediciNova, Inc. (MNOV) real-time quote, historical performance, charts, and other financial information to help you make more informed ...
MediciNova Inc. options quotes data for sells and puts, including MNOV last price, change and volume.
H1 Headings: | 4 | H2 Headings: | 6 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 34 |
Google Adsense: | Not Applicable | Google Analytics: | UA-110228973-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
IRニュース メディアイベント | 3 | 2.609 % | No |
研究開発 IRニュース | 3 | 2.609 % | No |
IRスケジュール アナリスト情報一覧 | 2 | 1.739 % | No |
決算短信 有価証券報告書 | 2 | 1.739 % | No |
株式情報 IRスケジュール | 2 | 1.739 % | No |
株主・投資家のみなさまへ IRニュース | 2 | 1.739 % | No |
有価証券報告書 四半期報告書 | 2 | 1.739 % | No |
IRニュース 財務情報 | 2 | 1.739 % | No |
株主総会資料 株主通信 | 2 | 1.739 % | No |
学会発表・論文関連資料 動画 | 2 | 1.739 % | No |
English 検索 | 2 | 1.739 % | No |
決算説明会資料 学会発表・論文関連資料 | 2 | 1.739 % | No |
株主通信 決算説明会資料 | 2 | 1.739 % | No |
クラッベ病 DCM(変性性頸椎脊椎症) | 2 | 1.739 % | No |
四半期報告書 株主総会資料 | 2 | 1.739 % | No |
IRライブラリー 決算短信 | 2 | 1.739 % | No |
トップメッセージ 理念・経営方針 | 2 | 1.739 % | No |
会社概要 経営メンバー | 2 | 1.739 % | No |
企業情報 トップメッセージ | 2 | 1.739 % | No |
メディアイベント 企業情報 | 2 | 1.739 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
詳しくはこちらから Page Top お問い合わせ | 1 | 0.87 % | No |
Page Top お問い合わせ よくあるご質問 | 1 | 0.87 % | No |
約0兆円 詳しくはこちらから Page Top | 1 | 0.87 % | No |
KEY NUMBER ファストトラック指定 0本 | 1 | 0.87 % | No |
IR INFORMATION KEY NUMBER | 1 | 0.87 % | No |
INFORMATION KEY NUMBER ファストトラック指定 | 1 | 0.87 % | No |
ご利用条件 東京事務所BLOG Copyright © | 1 | 0.87 % | No |
東京事務所BLOG Copyright © 2021 | 1 | 0.87 % | No |
MEDICINOVA Inc All Right | 1 | 0.87 % | No |
Inc All Right Reserverd | 1 | 0.87 % | No |
2021 MEDICINOVA Inc All | 1 | 0.87 % | No |
© 2021 MEDICINOVA Inc | 1 | 0.87 % | No |
Copyright © 2021 MEDICINOVA | 1 | 0.87 % | No |
20210622 メディア Maxim Group | 1 | 0.87 % | No |
20210623 メディア Zacks SmallCap | 1 | 0.87 % | No |
アナリスト情報一覧 English 検索 × | 1 | 0.87 % | No |
メディアイベント 20211021 MN001学会 第19回 | 1 | 0.87 % | No |
MN221 気管支喘息急性発作 MN029 固形がん | 1 | 0.87 % | No |
動画 ニュース 研究開発 IRニュース | 1 | 0.87 % | No |
検索 ニュース 研究開発 IRニュース | 1 | 0.87 % | No |
Domain Registrar: | Japan Registry Services |
---|---|
Registration Date: | 2006-04-07 1 decade 8 years 7 months ago |
Last Modified: | 2021-08-27 3 years 2 months 3 weeks ago |
Expiration Date: | 2022-04-30 2 years 6 months 3 weeks ago |
Owner's E-Mail: | [email protected] |
Host | IP Address | Country | |
---|---|---|---|
ns1.xbiz.ne.jp | 157.112.182.247 | Japan | |
ns2.xbiz.ne.jp | 35.76.79.244 | United States | |
ns3.xbiz.ne.jp | 157.112.191.237 | Japan |
Host | Type | TTL | Extra |
---|---|---|---|
medicinova.jp | A | 3593 |
IP: 183.90.231.41 |
medicinova.jp | NS | 3600 |
Target: ns1.xbiz.ne.jp |
medicinova.jp | NS | 3600 |
Target: ns3.xbiz.ne.jp |
medicinova.jp | NS | 3600 |
Target: ns2.xbiz.ne.jp |
medicinova.jp | SOA | 3600 |
MNAME: ns1.xbiz.ne.jp RNAME: root.xbiz.ne.jp Refresh: 10800 Retry: 3600 Expire: 604800 |
medicinova.jp | MX | 3600 |
Target: medicinova.jp |
medicinova.jp | TXT | 3600 |
TXT: v=spf1 +a:sv240.xbiz.ne.jp +a:medicinova.jp +mx ~all |
Largest selection of Kpop merch, hoodies, and more for your favorite groups and Korean style apparel. Get fast shipping and good prices at Kpoptify.
Canada's favorite brand of decorative paints has been sold by leading retailers and dealers for over 75 years. A PPG Architectural Coatings Canada brand.